Core Laboratories Inc. to Post FY2025 Earnings of $0.94 Per Share, Zacks Research Forecasts (NYSE:CLB)

Core Laboratories Inc. (NYSE:CLB) – Stock analysts at Zacks Research decreased their FY2025 earnings per share estimates for Core Laboratories in a research note issued on Thursday, April 18th. Zacks Research analyst T. Saha now expects that the oil and gas company will post earnings of $0.94 per share for the year, down from their prior estimate of $0.95. The consensus estimate for Core Laboratories’ current full-year earnings is $0.80 per share.

CLB has been the subject of a number of other research reports. Bank of America lowered their price target on Core Laboratories from $17.00 to $16.00 and set an “underperform” rating for the company in a research report on Monday, April 15th. Stifel Nicolaus dropped their target price on Core Laboratories from $21.00 to $17.00 and set a “hold” rating on the stock in a research report on Monday, February 5th. Finally, StockNews.com raised shares of Core Laboratories from a “sell” rating to a “hold” rating in a research report on Saturday, January 20th. Two analysts have rated the stock with a sell rating and three have assigned a hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $18.50.

Core Laboratories Price Performance

Shares of CLB opened at $16.96 on Monday. The company has a debt-to-equity ratio of 0.71, a current ratio of 2.53 and a quick ratio of 1.72. The company’s fifty day moving average price is $16.15 and its 200-day moving average price is $17.72. Core Laboratories has a 1-year low of $13.82 and a 1-year high of $27.94. The firm has a market capitalization of $794.75 million, a PE ratio of 19.72, a price-to-earnings-growth ratio of 0.97 and a beta of 2.40.

Core Laboratories (NYSE:CLB) last released its earnings results on Wednesday, January 31st. The oil and gas company reported $0.19 EPS for the quarter, missing analysts’ consensus estimates of $0.20 by ($0.01). Core Laboratories had a return on equity of 15.19% and a net margin of 8.03%. The company had revenue of $128.21 million during the quarter, compared to analyst estimates of $127.80 million. During the same quarter last year, the business earned $0.23 earnings per share.

Institutional Investors Weigh In On Core Laboratories

A number of hedge funds and other institutional investors have recently made changes to their positions in CLB. Boston Trust Walden Corp boosted its holdings in Core Laboratories by 3.6% during the third quarter. Boston Trust Walden Corp now owns 2,277,774 shares of the oil and gas company’s stock worth $54,689,000 after buying an additional 79,166 shares in the last quarter. Congress Asset Management Co. MA boosted its stake in shares of Core Laboratories by 17.6% during the 1st quarter. Congress Asset Management Co. MA now owns 1,606,745 shares of the oil and gas company’s stock worth $27,443,000 after acquiring an additional 240,989 shares in the last quarter. Fisher Asset Management LLC grew its position in shares of Core Laboratories by 21.6% during the 4th quarter. Fisher Asset Management LLC now owns 754,407 shares of the oil and gas company’s stock valued at $13,323,000 after acquiring an additional 134,227 shares during the period. Van ECK Associates Corp grew its position in shares of Core Laboratories by 1.0% during the 3rd quarter. Van ECK Associates Corp now owns 707,868 shares of the oil and gas company’s stock valued at $16,996,000 after acquiring an additional 6,703 shares during the period. Finally, Invesco Ltd. increased its stake in shares of Core Laboratories by 25.3% in the 3rd quarter. Invesco Ltd. now owns 436,459 shares of the oil and gas company’s stock valued at $10,479,000 after purchasing an additional 88,013 shares in the last quarter. Institutional investors and hedge funds own 97.81% of the company’s stock.

Core Laboratories Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, March 4th. Stockholders of record on Monday, February 12th were paid a $0.01 dividend. The ex-dividend date of this dividend was Friday, February 9th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.24%. Core Laboratories’s payout ratio is 4.65%.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.